1-3 of 3
Sadik Kassim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

G-CSF/Plerixafor Dual-Mobilized Donor Derived CD33CAR T-Cells As Potent and Effective AML Therapy in Pre-Clinical Models

Giacomo Canesin, Hillary Hoyt, Reid Williams, Mariana Silva, Melissa Chng, Christopher Cummins, Matthew Ung, Huan Qiu, John Shin, Jianxin Hu, Gary Ge, Julian Scherer, Tirtha Chakraborty, Sadik Kassim
Journal: Blood
Blood (2021) 138 (Supplement 1): 1716.
https://doi.org/10.1182/blood-2021-153868
Published: 2021
Journal Articles

An Innovative in Vitro Potency Assay Designed to Predict the Fate of Chimeric Antigen Receptors Modified T Cell Therapy Post Infusion in ALL

Junxia Wang, MD PhD, Mark Dudley, PhD, Therese Choquette, PhD, Margit Jeschke, PhD, Erik Rutjens, PhD, Sadik Kassim, PhD
Journal: Blood
Blood (2016) 128 (22): 5830.
https://doi.org/10.1182/blood.V128.22.5830.5830
Published: 2016
Journal Articles

Quantitative Multiplexed Immunohistochemistry Assays for Exploring CAR Modified T Cells and Checkpoint Inhibitors in Lymphoma Trials

Thai Hong Tran, PhD, Krupa Scott, MS, Shyun-Shyun Lee, Reshma Singh, PhD, Shawn Cogan, Jennifer Bordeaux, PhD, Hummel Jennifer, MD, Jelveh Lameh, PhD, Catherine Tribouley, Sadik Kassim, Shabnam Tangri, PhD, Naveen Dakappagari, PhD
Journal: Blood
Blood (2015) 126 (23): 2659.
https://doi.org/10.1182/blood.V126.23.2659.2659
Published: 2015